Sonic Incytes Medical
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
#309-1788 W 5th Ave, Vancouver, British ...Phone Number
(800) 881-0096Website
www.sonicincytes.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Sonic Incytes Medical
Sonic Incytes believes in creating accessible and affordable diagnostic solutions - with health insights you can count on - to improve patient care. Recognizing the rise of chronic liver disease, Sonic Incytes has made it its mission to reduce the disease by enabling routine assessment and improved management of liver health. Its breakthrough, point of care ultrasound solution, Velacur, is redefining the standard of care in quantifying chronic liver disease - with diagnostic accuracy comparable to MRI. Founded in 2017, Sonic Incytes is a health technology company headquartered in Vancouver, British Columbia, Canada. Follow us on Twitter, LinkedIn, YouTube and www.sonicincytes.com.Explore more
Sonic Incytes Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sonic Incytes Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Sonic Incytes Medical has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Sonic Incytes Medical has new funding data
Product Launch: Get notified when Sonic Incytes Medical launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Sonic Incytes Medical had a recent Job posting/layoffs
Check out if Sonic Incytes Medical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Sonic Incytes Medical
Earning: See what the market has to say on Sonic Incytes Medical recently announced quarterly report
Sonic Incytes Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Sonic Incytes Medical as Masked Content
Find more new buyers
Compare Similar Companies to Sonic Incytes Medical
Compare insights from companies similar to Sonic Incytes Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sonic Incytes Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sonic Incytes Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sonic Incytes Medical.
Sonic Incytes Medical financials insights
Gather financial insights about Sonic Incytes Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$2.8M
2021
Series A
$7.3M
Sonic Incytes Medical Tech Stack
A closer look at the technologies used by Sonic Incytes Medical
See more technologies
Most Recent Scoops
Person-Based
Funding
Funding
Funding
Sonic Incytes Medical News & Media
Sonic Incytes Medical Corp.'s $7.3 Million Series A Raise - Global Legal Chronicle
Fasken Martineau DuMoulin LLP assisted Sonic Incytes Medical Corp. on the transaction. Sonic Incytes Medical Corp., a health technology company focused on liver health, has raised US$7.3M …Sonic Incytes Medical Corp. Successfully Completes Series A Raise of US$7.3M to Accelerate Velacur™ Commercialization
VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its US$7.3M Series A with backing from Nimbus Synergies as the lead investor, and support from Nicola Wealth, Mint Venture Partners, Consortium Medteq, Wavemaker Three-Sixty Health, Gaingels and INP Capital, as well as notable angel investors.Velacur™ Data Presented at 2021 AASLD The Liver Meeting®
Greater measurement depth of novel imaging test for liver disease highlighted in presentation Greater measurement depth of novel imaging test for liver disease highlighted in presentationSonic Incytes Showcases Velacur™ at ACG 2021
Breakthrough imaging solution for liver health offers physicians an accurate, accessible and affordable way to manage emerging health crisis Breakthrough imaging solution for liver health offers physicians an accurate, accessible and affordable way to manage emerging health crisis
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Sonic Incytes Medical
Sign Up For FreeTo access detailed company insights
Sonic Incytes believes in creating accessible and affordable diagnostic solutions - with health insights you can count on - to improve patient care. Recognizing the rise of chronic liver disease, Sonic Incytes has made it its mission to reduce the disease by enabling routine assessment and improved management of liver health. Its breakthrough, poin... Read More
